BREAST CANCER
Universidad de Castilla-La Mancha
Ciudad Real, EspañaPublications in collaboration with researchers from Universidad de Castilla-La Mancha (1)
2022
-
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Frontiers in Oncology, Vol. 11